{"eventGroups":[{"description":"Ex vivo selective depletion of alloreactive donor T lymphocytes utilizing RFT5-SMPT-dgA, a specific anti-interleukin-2 receptor immunotoxin in HLA-matched, nonmyeloablative, peripheral blood stem cell transplantation for hematologic malignancies in older adults","id":"EG000","otherNumAffected":0,"otherNumAtRisk":22,"seriousNumAffected":22,"seriousNumAtRisk":22,"title":"RFT5-SMPT-dgA, an Anti-interleukin, Used in Transplants"}],"frequencyThreshold":"5","seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":8,"numEvents":8}],"term":"Non relapse deaths"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":10,"numEvents":10}],"term":"Relapse deaths"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":4,"numEvents":4}],"term":"Hospitalization"}],"timeFrame":"The adverse event reporting was collected for 7 years."}